| 臺北醫學大學 |
2014 |
Pharmaceutical composition for inhibiting osteoclast growth
|
Chang, DM;Huang, HS |
| 國立成功大學 |
2018-06-06 |
PHARMACEUTICAL COMPOSITION, METHODS FOR PREPARING AND USING THE SAME
|
WU-, CHOU SU;HAI-, WEN CHEN;TSUNG-, LIN TSAI;DAR-, BIN SHIEH;CHIA-, CHUN CHEN; 蘇五洲 |
| 國立成功大學 |
2018-06-06 |
PHARMACEUTICAL COMPOSITION, METHODS FOR PREPARING AND USING THE SAME 2
|
WU-, CHOU SU;HAI-, WEN CHEN;TSUNG-, LIN TSAI;DAR-, BIN SHIEH;CHIA-, CHUN CHEN; 蘇五洲 |
| 國立成功大學 |
2018-06-06 |
PHARMACEUTICAL COMPOSITION, METHODS FOR PREPARING AND USING THE SAME 3
|
WU-, CHOU SU;HAI-, WEN CHEN;TSUNG-, LIN TSAI;DAR-, BIN SHIEH;CHIA-, CHUN CHEN; 蘇五洲 |
| 國立臺灣大學 |
2008 |
Pharmaceutical contamination in residential, industrial, and agricultural waste streams: Risk to aqueous environments in Taiwan
|
Lin, Angela Yu-Chen; Yu, Tsung-Hsien; Lin, Cheng-Fang |
| 國家衛生研究院 |
2005-05 |
Pharmaceutical design of antimitotic agents based on combretastatins
|
Hsieh, HP;Liou, JP;Mahindroo, N |
| 國立政治大學 |
2007 |
Pharmaceutical Innovation and Health Outcomes: Empirical Evidence from Taiwan
|
Hsieh, Chee-Ruey;Lo, Kuang-Ta;Hong, Yi-Chen;Shih, Ya-Chen |
| 國立臺灣大學 |
2004 |
Pharmaceutical Patents and Public Health - Aspects of Taiwan and Asian Countries
|
謝銘洋 |
| 國家衛生研究院 |
2010-06 |
Pharmaceutical penetration of new drug and pharmaceutical market structure in Taiwan: hospital-level prescription of thiazolidinediones for diabetes
|
Tsai, YW;Wen, YW;Huang, WF;Kuo, KN;Chen, PF;Shih, HW;Lee, YC |
| 國立臺灣大學 |
2000 |
Pharmaceutical Perspective of Drug Therapy in Pediatrics
|
林慧玲; 高純琇; 陳瑞龍; LIN, FE-LIN; GAU, CHURN-SHIOUH; CHEN, RUSSEL RHEI-LONG |
| 國立臺灣大學 |
2000-07 |
Pharmaceutical Perspective of Drug Therapy in Pediatrics
|
Wu, Fe-lin Lin; Gau, Churn-Shiouh; Chen, Russel Rhei-Long |
| 國家衛生研究院 |
2011-02 |
Pharmaceutical poisoning exposure and outcome analysis in children admitted to the pediatric emergency department
|
Lin, YR;Liu, TH;Liu, TA;Chang, YJ;Chou, CC;Wu, HP |
| 國立交通大學 |
2014-12-08T15:37:29Z |
Pharmaceutical Poisoning Exposure and Outcome Analysis in Children Admitted to the Pediatric Emergency Department
|
Lin, Yan-Ren; Liu, Tzu-Hsuan; Liu, Tzu-An; Chang, Yu-Jun; Chou, Chu-Chung; Wu, Han-Ping |
| 臺北醫學大學 |
2004 |
Pharmaceutical regulation of biotech product toward international harmonization
|
王惠珀; Wang HP |
| 臺北醫學大學 |
2004 |
Pharmaceutical regulation of biotech product toward international harmonization
|
王惠珀; Wang HP |
| 臺北醫學大學 |
2004 |
Pharmaceutical Regulation Toward global Harmonization
|
王惠珀; Wang HP |
| 臺北醫學大學 |
2004 |
Pharmaceutical Regulation Toward global Harmonization
|
王惠珀; Wang HP |
| 臺北醫學大學 |
2002 |
Pharmaceutical regulatory update
|
王惠珀; Wang HP |
| 臺北醫學大學 |
2002 |
Pharmaceutical regulatory update
|
王惠珀; Wang HP |
| 嘉南藥理大學 |
2009 |
Pharmaceutical Science & Technology Today
|
Elsevier SDOL |
| 臺大學術典藏 |
2021-11-24T08:24:56Z |
Pharmaceutical treatment for spinal osteoporosis: Bisphosphonates, denosumab, SERMs and teriparatide
|
KEH-SUNG TSAI |
| 嘉南藥理大學 |
2008-12 |
Pharmaceutical wastewater treatment by membrane bioreactor process – a case study in southern Taiwan
|
Chia-Yuan Chang; Jing-Song Chang; Saravanamuthu Vigneswaran; Jaya Kandasamy |
| 中國醫藥大學 |
2012-04-04 |
Pharmaceutically-controlled replication of adenoviruses in mesenchymal stem cell-based cell carriers improves oncolytic virotherapy for advanced human renal cell carcinoma
|
(Wan-Chi Hsiao);宋賢穎(Shian-Ying Sung);廖佳慧;吳錫金(Wu,Hsi-Chin);謝嘉玲(Chia-Ling Hsieh)* |
| 臺大學術典藏 |
2014 |
Pharmaceuticals and personal care products in a mesoscale subtropical watershed and their application as sewage markers
|
Lv, M.; Sun, Q.; Hu, A.; Hou, L.; Li, J.; Cai, X.; Yu, C.-P.; CHANG-PING YU |
| 臺北醫學大學 |
2013 |
Pharmacist Conducted Medication Reconciliation at Hospital Admission using Information Technology
|
YY, Lee;LN, Kuo;YC, Chiang;Hou, JY;TY, Wu;MH, Hsu;HY, Chen |
